BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 17552031)

  • 1. Hepatitis C virus-related lymphoproliferative disorders: an overview.
    Zignego AL; Giannini C; Ferri C
    World J Gastroenterol; 2007 May; 13(17):2467-78. PubMed ID: 17552031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.
    Zignego AL; Ferri C; Pileri SA; Caini P; Bianchi FB;
    Dig Liver Dis; 2007 Jan; 39(1):2-17. PubMed ID: 16884964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
    Degasperi E; Aghemo A; Colombo M
    Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
    Ghinoi A; Mascia MT; Puccini R; Ferri C
    G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV infection: pathogenesis, clinical manifestations and therapy.
    Antonelli A; Ferri C; Galeazzi M; Giannitti C; Manno D; Mieli-Vergani G; Menegatti E; Olivieri I; Puoti M; Palazzi C; Roccatello D; Vergani D; Sarzi-Puttini P; Atzeni F
    Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S39-47. PubMed ID: 18570753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extrahepatic manifestations of HCV infection].
    Husa P
    Vnitr Lek; 2016; 62(9 Suppl 2):18-22. PubMed ID: 27723989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.
    Stefanova-Petrova DV; Tzvetanska AH; Naumova EJ; Mihailova AP; Hadjiev EA; Dikova RP; Vukov MI; Tchernev KG
    World J Gastroenterol; 2007 Dec; 13(48):6518-28. PubMed ID: 18161922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV-related lymphoproliferative disorders in the direct-acting antiviral era: From mixed cryoglobulinaemia to B-cell lymphoma.
    Cacoub P; Comarmond C; Vieira M; Régnier P; Saadoun D
    J Hepatol; 2022 Jan; 76(1):174-185. PubMed ID: 34600000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
    Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
    J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin diseases and hepatitis virus C infection].
    Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z
    Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV and lymphoproliferative diseases.
    Trépo C; Berthillon P; Vitvitski L
    Ann Oncol; 1998 May; 9(5):469-70. PubMed ID: 9653484
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
    Pozzato G; Mazzaro C; Gattei V
    Minerva Med; 2021 Apr; 112(2):215-227. PubMed ID: 33263375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
    Lamprecht P; Lerin-Lozano C; Merz H; Dennin RH; Gause A; Voswinkel J; Peters SO; Gutzeit O; Arlt AC; Solbach W; Gross WL
    Ann Rheum Dis; 2003 Dec; 62(12):1230-3. PubMed ID: 14644867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
    Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
    Wiznia LE; Laird ME; Franks AG
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1260-1270. PubMed ID: 28252812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
    Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
    JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
    Younossi Z; Park H; Henry L; Adeyemi A; Stepanova M
    Gastroenterology; 2016 Jun; 150(7):1599-1608. PubMed ID: 26924097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems.
    Milovanova SY; Lysenko Kozlovskaya LV; Milovanova LY; Mrykhin NN; Russkih AV; Muchin NA
    Ter Arkh; 2018 Jun; 90(6):112-120. PubMed ID: 30701914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV infection and extrahepatic manifestations.
    Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
    Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.